We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HSACU market cap is 2.13B. The company's latest EPS is USD -1.6321 and P/E is -19.07.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -64.03M | -64.26M | -78.48M | -61.8M | -61.55M |
Net Income | -63.23M | -59.43M | -73.94M | -58.66M | -51.42M |
Year End March 30 2023 | 2018 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | 0 | -66.08M | -108.12M | -156.03M | -218.28M |
Net Income | 0 | -66.39M | -107.43M | -156.73M | -210.96M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 456.24M | 405.84M | 351.22M | 292.07M | 711.45M |
Total Liabilities | 41.57M | 43.34M | 51.36M | 40.26M | 32.1M |
Total Equity | 414.68M | 362.49M | 299.87M | 251.81M | 679.34M |
Year End March 30 2023 | 2018 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 405k | 109.39M | 412.49M | 515.56M | 405.84M |
Total Liabilities | 380k | 15.32M | 21.01M | 45.74M | 43.34M |
Total Equity | 25k | 94.07M | 391.48M | 469.83M | 362.49M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -132.4M | -188.19M | -47.37M | -107.43M | -154.53M |
Investing | -171k | -197k | -45k | -79k | -210k |
Financing | 70.65M | 70.89M | 890k | 1.04M | 470.88M |
Year End March 30 2023 | 2018 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -53.36M | -83.33M | -106.11M | -188.19M |
Investing | N/A | -31k | -210k | -254k | -197k |
Financing | 325k | 146.97M | 383.11M | 200.13M | 70.89M |
Market Cap | 2.13B |
Price to Earnings Ratio | -19.07 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 10.68 |
Price to Book Ratio | 11.1 |
Dividend Yield | - |
Shares Outstanding | 129.26M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 199.99k (99.99%) |
Company Name | Health Sciences Acquisitions Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.immunovant.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions